Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03907852
Title Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors TCR2 Therapeutics
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, San Francisco Recruiting San Francisco California 94143 United States Details
University of Miami Sylvester Cancer Center Recruiting Miami Florida 33136 United States Details
National Cancer Institute Recruiting Bethesda Maryland 20814 United States Details
Columbia University Medical Center Recruiting New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Recruiting Toronto Ontario M5G 2C1 Canada Details
*Shaded cells indicate that there was no data available from for the field